Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(1.10)
# 3,536
Out of 4,334 analysts
410
Total ratings
37.2%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Reiterated: Hold | $42 | $45.03 | -6.73% | 9 | May 19, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $1.07 | +180.37% | 19 | May 15, 2026 | |
| SEER Seer, Inc. | Reiterated: Buy | $4 | $1.79 | +123.46% | 2 | May 14, 2026 | |
| XGN Exagen | Maintained: Buy | $8 | $4.26 | +87.79% | 25 | May 11, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $1.22 | +145.90% | 33 | May 8, 2026 | |
| NTRA Natera | Reiterated: Buy | $285 | $203.19 | +40.26% | 34 | May 8, 2026 | |
| GH Guardant Health | Reiterated: Buy | $135 | $118.95 | +13.49% | 37 | May 8, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $32 | $23.68 | +35.14% | 26 | May 8, 2026 | |
| QSI Quantum-Si incorporated | Maintained: Hold | $1 | $1.06 | -5.66% | 22 | May 8, 2026 | |
| CAI Caris Life Sciences | Reiterated: Hold | $22 | $15.55 | +41.48% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.69 | +48.70% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 | $115.06 | +26.02% | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $20.15 | +98.51% | 26 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $67.19 | +19.07% | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $46.18 | +73.24% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $22 | $14.93 | +47.35% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $75 | $47.31 | +58.53% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $140 | $144.41 | -3.05% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $200 | $129.40 | +54.56% | 8 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $0.0002 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $15 | $15.10 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $6.39 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.13 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.41 | n/a | 1 | Jan 28, 2021 |
Veracyte
May 19, 2026
Reiterated: Hold
Price Target: $42
Current: $45.03
Upside: -6.73%
Lucid Diagnostics
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Seer, Inc.
May 14, 2026
Reiterated: Buy
Price Target: $4
Current: $1.79
Upside: +123.46%
Exagen
May 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.26
Upside: +87.79%
Pacific Biosciences of California
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Natera
May 8, 2026
Reiterated: Buy
Price Target: $285
Current: $203.19
Upside: +40.26%
Guardant Health
May 8, 2026
Reiterated: Buy
Price Target: $135
Current: $118.95
Upside: +13.49%
10x Genomics
May 8, 2026
Reiterated: Buy
Price Target: $32
Current: $23.68
Upside: +35.14%
Quantum-Si incorporated
May 8, 2026
Maintained: Hold
Price Target: $1
Current: $1.06
Upside: -5.66%
Caris Life Sciences
May 8, 2026
Reiterated: Hold
Price Target: $22
Current: $15.55
Upside: +41.48%
May 7, 2026
Reiterated: Hold
Price Target: $4
Current: $2.69
Upside: +48.70%
May 6, 2026
Maintained: Hold
Price Target: $145
Current: $115.06
Upside: +26.02%
May 6, 2026
Maintained: Buy
Price Target: $40
Current: $20.15
Upside: +98.51%
May 6, 2026
Reiterated: Buy
Price Target: $80
Current: $67.19
Upside: +19.07%
May 6, 2026
Reiterated: Buy
Price Target: $80
Current: $46.18
Upside: +73.24%
May 5, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $14.93
Upside: +47.35%
May 5, 2026
Reiterated: Buy
Price Target: $100 → $75
Current: $47.31
Upside: +58.53%
May 1, 2026
Reiterated: Hold
Price Target: $150 → $140
Current: $144.41
Upside: -3.05%
Apr 20, 2026
Maintained: Buy
Price Target: $250 → $200
Current: $129.40
Upside: +54.56%
Jul 29, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $0.0002
Upside: n/a
Jun 1, 2021
Maintained: Buy
Price Target: $13 → $15
Current: $15.10
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $6.39
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $3.13
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.41
Upside: n/a